MSH6 and colorectal cancer: MMR deficient MSH6 mutant DLD-1 human colorectal cancer cells with a high spontaneous mutation rate and a typical MMRd mutation spectrum (12,28) and MMR proficient TK6 human lymphoblastoma cells with a low mutation rate (44) were chosen for the study.